Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengdi Wang

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
BMC Cancer|June 11, 2024
Investigating causal associations between pneumonia and lung cancer using a bidirectional mendelian randomization frameworkLujia Song, Dongsheng Wu, Jiayang Wu, et al.
Bioscience Reports|April 22, 2020
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancerJun Shao, Chengdi Wang, Pengwei Ren, et al.
Chinese Medical Journal|July 2, 2023
Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 casesChengdi Wang, Jun Shao, Lujia Song, et al.
Cancer Letters|August 30, 2020
CircRNAs in lung cancer - Biogenesis, function and clinical implicationChengdi Wang, Shuangyan Tan, Jingwei Li, et al.
Thrombosis Research|December 3, 2014
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysisJiarong Wang, Chengdi Wang, Nan Chen, et al.
Scientific Reports|August 26, 2017
Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located Liver Tumors: A Meta-AnalysisJianbo Li, Chengdi Wang, Jiulin Song, et al.
Annals of Translational Medicine|November 26, 2020
A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patientsJun Shao, Chengdi Wang, Jingwei Li, et al.
Frontiers in Immunology|March 7, 2022
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT ImagesChengdi Wang, Jiechao Ma, Jun Shao, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2020
Clinical and molecular characteristics associated with survival among cancer patients receiving first-line anti-PD-1/PD-L1-based therapiesYaojie Zhou, Chengdi Wang, Yuting Jiang, et al.
International Immunopharmacology|May 18, 2024
The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort studyChenyang Zhang, Jun Shao, Xiaolong Tang, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
BMC Cancer|June 11, 2024
Investigating causal associations between pneumonia and lung cancer using a bidirectional mendelian randomization frameworkLujia Song, Dongsheng Wu, Jiayang Wu, et al.
Bioscience Reports|April 22, 2020
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancerJun Shao, Chengdi Wang, Pengwei Ren, et al.
Chinese Medical Journal|July 2, 2023
Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 casesChengdi Wang, Jun Shao, Lujia Song, et al.
Cancer Letters|August 30, 2020
CircRNAs in lung cancer - Biogenesis, function and clinical implicationChengdi Wang, Shuangyan Tan, Jingwei Li, et al.
Thrombosis Research|December 3, 2014
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysisJiarong Wang, Chengdi Wang, Nan Chen, et al.
Scientific Reports|August 26, 2017
Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located Liver Tumors: A Meta-AnalysisJianbo Li, Chengdi Wang, Jiulin Song, et al.
Annals of Translational Medicine|November 26, 2020
A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patientsJun Shao, Chengdi Wang, Jingwei Li, et al.
Frontiers in Immunology|March 7, 2022
Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT ImagesChengdi Wang, Jiechao Ma, Jun Shao, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2020
Clinical and molecular characteristics associated with survival among cancer patients receiving first-line anti-PD-1/PD-L1-based therapiesYaojie Zhou, Chengdi Wang, Yuting Jiang, et al.
International Immunopharmacology|May 18, 2024
The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort studyChenyang Zhang, Jun Shao, Xiaolong Tang, et al.
Pageof 11